Speaker Profile

M.D., Chairman and CEO, ArsenalBio

Biography
Ken Drazan, MD, is the Chairman, CEO, and Co-Founder of ArsenalBio, a pioneering company in the field of cell therapy and gene editing. Prior to his role at ArsenalBio, Dr. Drazan served as President and Chief Business Officer of GRAIL, a company focused on early cancer detection which was acquired by Illumina. He also founded and was a Board Director at Verb Surgical, which was later acquired by Johnson Johnson. Additionally, Dr. Drazan co-founded Bertram Capital, a private equity firm managing $1.9 billion in assets. He earned his medical degree from Yale University. Throughout his career, Dr. Drazan has been instrumental in advancing technologies that leverage AI and high-performance computing in precision medicine, significantly impacting the fields of gene editing and cell therapy.


 Session Abstract – PMWC 2025 Silicon Valley

Track 2 - February 7 9.00 A.M.-3.00 P.M.


Track Chair:
Gad Getz, Broad Institute

  • PMWC 2025 Luminary Award
    Luminary Honoree: Jensen Huang, Nvidia
  • Continued Jensen Huang, Nvidia
  • Predictive Modeling for Drug Development
    - Luca Emili, InSilicoTrials
  • Knowledge Graphs, LLMs & Foundation Models for Enhanced Drug Development
    - Janusz Dutkowski, Data4Cure
    - Paul Rejto, Pfizer
  • PMWC Showcase
    - Peter Ellman, Certis Oncology
  • Beyond LLMs: Harnessing Advanced AI Models for Genomics and Transcriptomics (PANEL)
    Chair: Gad Getz, Broad Institute
    - Yasin Şenbabaoğlu, CZ Biohub San Francisco
    - Orly Alter, PrismAI
    - Nicolo Fusi, Microsoft
  • Empowering AI in Precision Medicine with Federated Data Platforms
    - Noah Nasser, Datma
  • Advancing Global Health through Data Sharing: Practical Strategies and Success Stories (PANEL)
    Chair: Luca Foschinii, Sage Bionetworks
    - Peter Goodhand, GA4GH
    - Karen Miga, UCSC
    - Philip Awadalla, Ontario Institute for Cancer Research
  • Driving Drug Discovery With Low-cost Foundational Omics Datasets
    - Gilad Almogy, Ultima Genomics
    - Johnny Yu, Vevo Therapeutics
    - Stacie Calad-Thomson, NVDIA
  • Enabling Targeted Precision Drug & Gene Delivery with Predictive AI
    - Andre Watson, Ligandal Inc.
  • Quantum Leap: The Future of AI and Machine Learning with Quantum Computing
    - Matthias Troyer, Microsoft

×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by JUL. 31ST

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.
  • This field is for validation purposes and should be left unchanged.

Contact Us:

Fields marked with an * are required 

  • This field is for validation purposes and should be left unchanged.

Contact Us:

Fields marked with an * are required 

  • This field is for validation purposes and should be left unchanged.

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


  • This field is for validation purposes and should be left unchanged.

Contact Us:

Fields marked with an * are required 

  • Example Message - I am interested in exhibiting, please let me know the rates...
  • This field is for validation purposes and should be left unchanged.

Trouble Registering

Fields marked with an * are required

  • This field is for validation purposes and should be left unchanged.

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required
  • This field is for validation purposes and should be left unchanged.